José Alcamí Pertejo

Cellular and Humoral Functional Responses After BNT162b2 SARS-CoV-2 mRNA Vaccination Differ Between Naïve and COVID-19-Recovered Individuals

E. López-Collazo, A. Cascajero, J. García-Pérez, 2021, SSRN Electronic Journal.

Reactogenicity and Immunogenicity of BNT162b2 in Subjects Having Received a First Dose of ChAdOx1s: Initial Results of a Randomised, Adaptive, Phase 2 Trial (CombiVacS)

A. Borobia, A. Carcas, D. Lora, 2021, SSRN Electronic Journal.